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Abstract: Antimicrobial resistance is one of the major threats to the health and welfare of both humans
and animals. The shortage of new antimicrobial agents has led to the re-evaluation of old antibiotics
such as fosfomycin as a potential regimen for treating multidrug-resistant bacteria especially extended-
spectrum-beta-lactamase- and carbapenemase-producing Enterobacteriaceae. Fosfomycin is a broad-
spectrum bactericidal antibiotic that inhibits the initial step of the cell wall biosynthesis. Fosfomycin
resistance can occur due to mutation in the drug uptake system or by the acquisition of fosfomycin-
modifying enzymes. In this review, we focus on mobile fosfomycin-resistant genes encoding glutathione-
S-transferase which are mainly responsible for fosfomycin resistance in Enterobacteriaceae, that is, fosA
and its subtypes, fosC2, and the recently described fosL1-L2. We summarized the proposed origins of the
different resistance determinants and highlighted the different plasmid types which are attributed to the
dissemination of fosfomycin-modifying enzymes. Thereby, IncF and IncN plasmids play a predominant
role. The detection of mobile fosfomycin-resistant genes in Enterobacteriaceae has increased in recent
years. Similar to the situation in (East) Asia, the most frequently detected fosfomycin-resistant gene
in Europe is fosA3. Mobile fosfomycin-resistant genes have been detected in isolates of human, animal,
food, and environmental origin which leads to a growing concern regarding the risk of spread of such
bacteria, especially Escherichia coli and Salmonella, at the human-animal-environment interface.
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1  |  INTRODUC TION
Fosfomycin, originally known as phosphonomycin, was discovered 
five decades ago and has been approved for the treatment of un-
complicated urinary tract infections (UTI) since early 1970 (Silver, 
2017). The phosphonic acid-derived antibiotic containing an epoxide 
and a propyl group possesses a unique chemical structure and the 
mechanism of action comprising broad-spectrum activity against 
Gram-negative and Gram-positive aerobic bacteria is unrelated to 
any other antibiotic family (Castañeda-García et al., 2013; Silver, 
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humans and animals. The shortage of new antimicrobial agents has led to the re-
evaluation of old antibiotics such as fosfomycin as a potential regimen for treating 
multidrug-resistant bacteria especially extended-spectrum-beta-lactamase- and car-
bapenemase-producing Enterobacteriaceae. Fosfomycin is a broad-spectrum bacte-
ricidal antibiotic that inhibits the initial step of the cell wall biosynthesis. Fosfomycin 
resistance can occur due to mutation in the drug uptake system or by the acquisition 
of fosfomycin-modifying enzymes. In this review, we focus on mobile fosfomycin-
resistant genes encoding glutathione-S-transferase which are mainly responsible for 
fosfomycin resistance in Enterobacteriaceae, that is, fosA and its subtypes, fosC2, and 
the recently described fosL1-L2. We summarized the proposed origins of the differ-
ent resistance determinants and highlighted the different plasmid types which are 
attributed to the dissemination of fosfomycin-modifying enzymes. Thereby, IncF and 
IncN plasmids play a predominant role. The detection of mobile fosfomycin-resistant 
genes in Enterobacteriaceae has increased in recent years. Similar to the situation 
in	 (East)	Asia,	 the	most	frequently	detected	fosfomycin-resistant	gene	 in	Europe	 is	
fosA3. Mobile fosfomycin-resistant genes have been detected in isolates of human, 
animal, food, and environmental origin which leads to a growing concern regarding 
the risk of spread of such bacteria, especially Escherichia coli and Salmonella, at the 
human–animal–environment interface.
K E Y W O R D S
antimicrobial resistance, dissemination, Enterobacteriaceae, transferrable fosfomycin 
resistance
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2017). Fosfomycin has a bactericidal effect by inhibiting the initial 
step in the biosynthesis of peptidoglycan. It acts as a phosphoe-
nolpyruvate	 (PEP)	 analogue	and	binds	 the	essential	 enzyme	MurA	
(UDP-N-acetylglucosamine enolpyruvyl transferase) leading to bac-
terial cell lysis and death (Castañeda-García et al., 2013; Kahan et al., 
1974).
The shortage of new antimicrobial agents has led to the re-eval-
uation of old antibiotics such as fosfomycin and colistin as potential 
treatment options against multidrug-resistant (MDR) bacteria espe-
cially extended-spectrum-beta-lactamase- and carbapenemase-pro-
ducing Enterobacteriaceae, that is, the use of fosfomycin in other 
indications as uncomplicated UTI and potentially in combination 
with other antibiotics (Falagas et al., 2010; Samonis et al., 2012; 
Silver, 2017).
Three	major	 fosfomycin	 resistance	mechanisms	have	been	de-
scribed: (a) reduced permeability to fosfomycin, (b) modification of 
the	antibiotic	target	MurA,	and	(c)	antibiotic	modification,	whereas	
reduced drug uptake remains the most frequently encountered 
resistance mechanism among clinical isolates as well as in in vitro 
obtained mutants (Castañeda-García et al., 2013; Nilsson et al., 
2003; Silver, 2017). In Escherichia coli, this chromosomally encoded 
resistance mechanism is based on mutations in two main nutri-
ent transport systems which are responsible for the fosfomycin 
uptake, namely the glycerol-3-phosphate transporter (GlpT) and 
the glucose-6-phosphate transporter (UhpT) (Kahan et al., 1974). 
In general, modification of the antibiotic target is one of the most 
common mechanisms to acquire antibiotic resistance in bacteria. 
However,	modifications	of	MurA	seem	to	be	rare	in	clinical	isolates.	
Nevertheless, it has been shown that overexpression of the murA 
gene contributes to the acquisition of clinical levels of fosfomycin 
resistance at low fitness cost (Couce et al., 2012). These chromo-
somal resistance mechanisms have been recently reviewed in detail 
(Castañeda-García et al., 2013; Silver, 2017).
Meanwhile, several fosfomycin-modifying enzymes have 
been characterized that lead to the inactivation of the drug. 
Fosfomycin-producing microorganisms such as some strains of 
Streptomyces and Pseudomonas syringae exhibit antibiotic kinases 
(FomA	or	FomB)	that	modify	and	detoxify	the	antibiotic	inside	the	
cell by phosphorylation (Kobayashi et al., 2000). In clinical import-
ant pathogenic bacteria, fosfomycin resistance involves metallo-
enzymes that catalyze the opening of the epoxide (oxirane) ring 
by	adding	glutathione	(FosA1-FosA10,	FosL1-2,	FosC2),	bacillithiol	
(FosB),	or	water	(FosX)	(Rigsby	et	al.,	2005).	FosB	(Mg2+-cofactor) 
type enzymes are found in low GC Gram-positive bacteria such as 
Bacillus subtilis, B. anthracis, Staphylococcus epidermidis, and S. au-
reus.	 FosX	 (Mn2+-cofactor) has been described in Gram-positive 
bacteria such as Listeria monocytogenes, Clostridium botulinum, and 
Brucella melitensis (Silver, 2017). In this review, we will focus on 
fosA and its subtypes, fosC2, and the recently described fosL1-L2 
since these genes are mainly responsible for fosfomycin resistance 
in Enterobacteriaceae.
In Enterobacteriaceae, genes encoding fosfomycin-modifying 
enzymes are frequently found on plasmids, transposons, or within 
integrons. Regardless of the location (chromosomal or plasmid), 
insertion sequences are often found in proximity indicating mo-
bilization of these genes. These facts enable rapid dissemination 
and	indeed,	fosfomycin-modifying	enzymes	are	widespread	in	Asia	
where most of these genes initially have been described. Moreover, 
plasmids carrying fos-genes commonly harbor additional resistance 
genes that foster the chance of co-selection of fosfomycin resistance 
under the selective pressure by other antibiotics (Poirel et al., 2018).
The efficacy of fosfomycin against extended-spectrum beta-lac-
tamase	(ESBL)-producing	Enterobacteriaceae	is	favorable	although	
increasing fosfomycin resistance rates due to fosfomycin-modifying 
enzymes	have	been	observed	among	ESBL-producing	and	carbapen-
emase-producing Enterobacteriaceae in the last decade, primarily in 
Asia	but	more	and	more	globally	(Baron	et	al.,	2020;	Benzerara	et	al.,	
2017;	Chan	et	al.,	2014;	Fernandes	et	al.,	2018;	Ho,	Chan,	Lo,	Lai,	
et al., 2013; Hou et al., 2012; Wachino et al., 2010).
Co-selection and frequent use of fosfomycin are important fac-
tors in resistance development and dissemination. Fosfomycin is ap-
proved for use against uncomplicated UTI almost all over the world. 
In	some	European	countries,	that	is,	Spain,	France,	Germany,	Austria,	
and Greece, the intravenous formulation is administered in combina-
tion with other antibiotics for the treatment of nosocomial infections 
due to multidrug-resistant (MDR) Gram-positive and Gram-negative 
bacteria (Michalopoulos et al., 2011). In contrast, fosfomycin is not 
approved for veterinary use in most countries including China and 
Europe (Wang et al., 2017). However, fosfomycin is widely used in 
farms	 in	 Argentina,	 Brazil,	 and	 Central	 America,	 primarily	 for	 the	
treatment of infectious diseases in broiler chickens and pigs (Pérez 
et al., 2014).
2  |  ORIGIN OF FOSA  GENES
Ito and colleagues systematically surveyed the presence and distri-
bution of the fosA	genes	in	over	18,000	published	genome	sequences	
from 18 Gram-negative species (Ito et al., 2017). They propose the 
chromosomal location of fosA in the genomes of Providencia stuar-
tii, Klebsiella pneumoniae, Serratia marcescens, Pseudomonas aerugi-
nosa, Enterobacter aerogenes, Klebsiella oxytoca, Morganella morganii, 
Providencia rettgeri, and Enterobacter cloacae based on the high prev-
alence of fosA (>80%) in the respectively analyzed genomes. In con-
trast, fosA was rarely (<5%) detected in E. coli, Citrobacter freundii, 
and Acinetobacter baumannii which indicated a possible acquisition 
of	 the	gene.	Furthermore,	 they	could	show	an	extensive	FosA	se-
quence diversity both within and between species. Noteworthy, 
key residues in the active site of the enzyme, as well as residues 
involved in fosfomycin binding, are highly conserved across the dif-
ferent	FosA	proteins	(Castañeda-García	et	al.,	2013;	Ito	et	al.,	2017;	
Poirel et al., 2019).
Since the nomenclature of fosA has lacked consistency, it is pro-
posed to distinguish between intrinsic versus acquired and chromo-
somal versus plasmid-mediated origin, respectively (Ito et al., 2017). 
Thus, chromosomal or intrinsic fosA/FosA	should	be	distinguished	
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by adding the initials of the species whereas the numbering scheme 
should be reserved for acquired fosA/FosA	(Ito	et	al.,	2017).
The	origins	of	plasmid-mediated	FosA	alleles	are	summarized	in	
Table 1. The first plasmid-mediated fosA gene, fosA1 (also known 
as fosATn2921), was described in a clinical isolate in Spain. FosA1 was 
located within Tn2921 on plasmid pSU912 in S. marcescens (Navas 
et	al.,	1990).	FosA1	 is	up	 to	100%	 identical	with	FosEC, the fosfo-
mycin-modifying enzyme found in the chromosome of E. cloacae 
which	is	the	likely	origin	of	FosA1	(Ito	et	al.,	2017).	Importantly,	plas-
mid-mediated	FosA1	is	distinct	from	FosASM which is generally pres-
ent in the S. marcescens chromosome.
The	 origin	 of	 FosA3,	 the	 most	 widely	 disseminated	 acquired	
fosfomycin-modifying enzyme, was speculated to be K. pneumoniae 
after	early	reports	(Lee	et	al.,	2012;	Wachino	et	al.,	2010).	The	result	
of	a	more	recent	study	showed	that	FosA3	 is	most	closely	related	
to	 FosAKG (>94% identity) from Kluyvera georgiana among known 
chromosomally	 encoded	 FosA	 (Ito	 et	 al.,	 2018).	 Furthermore,	 sur-
rounding sequences were highly similar in K. georgiana YDC799 to 
corresponding regions of several plasmid-mediated fosA3 of E. coli 
(Ito et al., 2017). IS26 seems to be the key element in the mobiliza-
tion of fosA3 since it commonly composes a composite transposon 
surrounding fosA3 by two IS26 elements oriented in the opposite 
direction. The same IS26-composite transposons frequently contain 
additionally a blaCTX-M gene (Yang et al., 2019). However, various 
truncations in the fosA3 surrounding regions by IS26 and other IS 
elements may give evidence for multiple independent mobilization 
events	(Ito	et	al.,	2018;	Yang	et	al.,	2019).	The	origin	of	FosA4,	which	
shares	 94%	 amino	 acid	 identity	 with	 FosA3,	 was	 similarly	 traced	
back to K. georgiana (Rodriguez et al., 2018).
The highly similar fosA5, fosA6, and fosA10 genes (less than 10 
nucleic acid sequence differences) were proposed to originate from 
the K. pneumoniae chromosome (Guo et al., 2016; Huang et al., 2020; 
Ma et al., 2015). In all three genes, lysR genes truncated by IS10 were 
present upstream of the fosA gene. The downstream fragments of 
fosA5, fosA6, and fosA10 varied thus separate mobilization events of 
fosAKP were likely (Guo et al., 2016; Huang et al., 2020; Ma et al., 
2015).
The plasmid-encoded fosA8, recently described in an E. coli iso-
late recovered from urine, showed the highest identity with a fosA 
gene identified in the chromosome of the enterobacterial species 
Lecleria adecarboxylata. This species is a rare source of infections in 
humans and is intrinsic resistant to fosfomycin probably due to high 
expression levels of the fosALA gene (Poirel et al., 2019).
FosA9 was first described in an E. coli isolate from a blood culture 
of a patient (ten Doesschate et al., 2019). The patient had a suspi-
cion of chronic endovascular infection of the aortic bifurcation graft 
and had a history of recurrent episodes of sepsis with blood cultures 
yielding Propionibacterium spp., Klebsiella variicola, Citrobacter koseri, 
and P. aeruginosa. The patient also suffered a septic shock caused by 
E. coli which was treated with intravenous ceftriaxone. The treat-
ment to suppress the chronic infection (amoxicillin/clavulanic acid 
and ciprofloxacin) was complemented with oral fosfomycin treat-
ment since the E. coli isolate was resistant against the previously 
used antibiotic combination. Months later, E. coli with an identical 
resistance pattern could still be isolated from blood cultures, except 
for being additionally resistant to fosfomycin. Fosfomycin resistance 
could be traced back to the acquisition of a 3573 bp insertion includ-
ing ISEcp1 and a fosA gene which was named fosA9. Genetic analysis 
FosA allele
Possible chromosomal 
origin Accession no. Reference
FosA1	(FosATn2921) Enterobacter cloacae M85195.1 Navas et al. 
(1990)
FosA3 Kluyvera georgiana AB522970.2 Wachino et al. 
(2010)
FosA4 Kluyvera georgiana AB908992.1 Nakamura et al. 
(2014)
FosA5	(FosKp96) Klebsiella pneumoniae KP143090 Ma et al. (2015)
FosA6 Klebsiella pneumoniae KU254579.1 Guo et al. (2016)
FosA8 Leclercia decarboxylata MN150127 Poirel et al. 
(2019)
FosA9 Klebsiella variicola PRJEB32329 ten Doesschate 
et al. (2019)
FosA10 Klebsiella pneumoniae MT074415 Huang et al. 
(2020)
FosL1 Unknown MN464149 Kieffer et al. 
(2020)
FosL2 Unknown SAMN11027629 Kieffer et al. 
(2020)
FosC2 Unknown AB522969 Wachino et al. 
(2010)
TA B L E  1 Origin	of	plasmid-mediated	
FosA	alleles
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of fosA revealed K. variicola to be the likely source of fosA9 acquired 
by E. coli. The authors hypothesized that fosA9 was transferred from 
K. variicola to E. coli in the gastrointestinal tract since K. variicola was 
not co-cultured in the blood at the time of E. coli bacteraemia (ten 
Doesschate et al., 2019).
FosA2	 and	 FosA7	 were	 reported	 as	 chromosomal	 variants	 of	
FosA	 of	E. cloace and S. enterica serovar Heidelberg, respectively, 
and	they	would	be	named	FosAEC	and	FosASH in the newly proposed 
nomenclature (Ito et al., 2017).
The chromosomal progenitor of the recently reported plas-
mid-mediated fosfomycin resistance genes fosL1 and fosL2 and the 
origin of fosC2 is still unclear. FosC2 is a rarely described fosfomy-
cin-modifying	enzyme	identified	on	a	conjugative	plasmid	in	E. coli 
in Japan (Wachino et al., 2010). This gene was not yet detected in 
Europe.
3  |  PL A SMID T YPES INVOLVED IN 
THE DISSEMINATION OF FOSFOMYCIN-
MODIF YING ENZ YMES AMONG 
ENTEROBAC TERIACE AE
The most common plasmid families in Enterobacteriaceae involved 
in	 the	 spread	 of	 antimicrobial	 resistance	 genes	 are	 IncA/C,	 IncL	
(previously	designated	IncL/M),	IncF,	IncI,	IncH,	and	IncN	(Carattoli,	
2013; Rozwandowicz et al., 2018). In Europe, fosfomycin-modify-
ing enzymes were present on plasmids belonging to the IncF, IncN, 
IncA/C,	IncHI2,	and	IncX1	family,	whereas	IncF	is	the	predominant	
plasmid incompatibility type. Some fosA-encoding plasmids were 
not	typeable.	An	overview	of	fosA gene-carrying plasmids from en-
terobacterial	 isolates	 in	 Europe	 is	 shown	 in	 Table	 2.	 FosA3	 is	 the	
most frequently found fosfomycin-modifying enzyme worldwide 
(Yang et al., 2019). The dissemination of the fosA3 gene is closely 
associated	with	that	of	the	ESBL	gene	blaCTX-M. In Europe, fosA3 was 
described in E. coli-producing	 CTX-M-15,	 CTX-M-55,	 CTX-M-14,	
CTX-M-3,	CTX-M-65,	CTX-M-9,	CTX-M-27,	CTX-M-125,	and	CTX-
M-2. The predominant vehicles of fosA3 are IncFII plasmids including 
F2:A-:B-,	 F33:A1:B1,	 and	F33:A-:B-	 (Baron	et	 al.,	 2020;	Benzerara	
et	al.,	2017a;	Lupo	et	al.,	2018;	Mendes	et	al.,	2016).	IncF	plasmids	
are limited by host range to the family of Enterobacteriaceae and are 
usually low copy number plasmids >100 kb in size (Carattoli, 2013). 
IncFII	plasmids	(F2:A-:B-,	F33:A-:B-	and	others)	also	play	a	key	role	
in the dissemination of fosA3 among clinical isolates, companion, 
and	food	animals	in	Asian	countries	(Ho,	Chan,	Lo,	Lai,	et	al.,	2013;	
Ho,	Chan,	Lo,	Law,	et	al.,	2013;	Hou	et	al.,	2012;	Yang	et	al.,	2014).	
Plasmids identified in Europe show highly similar molecular features 
even though a direct link could not be made in most cases.
FosA-encoding IncN plasmids varied in size (50–225 kb) and in 
the number of resistance genes they carry. The two fosA3-positive 
IncN plasmids were found in sprouts and harbored blaCTX-M-65 and 
blaCTX-M-125	ESBL	genes,	respectively.	IncN/ST8	co-harboring	fosA3 
and blaCTX-M-65 have been described in pig and duck samples from 
China in the early 2000 s (Hou et al., 2013).
In France, a fosA5-carrying IncN plasmid was identified in a 
patient simultaneously with the original description of fosA5 on 
an	IncA/C	background	in	China	(Benzerara	et	al.,	2017a;	Ma	et	al.,	
2015). The fosA5-variant was previously designated as fosKP96 and 
has been described on 50 kb IncN plasmids in China in a urine and 
blood	isolate,	respectively	(Ho,	Chan,	Lo,	Lai,	et	al.,	2013).
Recently, a novel distinct fosA-variant, fosA8, was identified 
from	 a	 CTX-M-15-producing	 E. coli isolate recovered from urine 
in Switzerland. Mating-out experiments revealed the presence of 
fosA8	on	a	self-conjugative	IncN	plasmid	that	also	carried	a	kanamy-
cin resistance marker. In contrast to fosA3-plasmids, this plasmid did 
not carry the blaCTX-M-15	ESBL	gene	identified	in	this	isolate	(Poirel	
et al., 2019).
In one isolate from sprouts, fosA3	was	located	on	a	conjugative	
245 kb IncHI2 plasmid. This plasmid additionally encoded genes for 
ESBL	 (blaCTX-M-14), florfenicol resistance (floR), aminoglycoside re-
sistance (aac(3)-Iva), sulfonamide resistance (sul2), and tetracycline 
resistance (tetA(A))	(Freitag	et	al.,	2018).	IncHI2	plasmids	are	usually	
large plasmids (>250 kb) and are frequently encountered in clinical 
enterobacterial isolates associated with the dissemination of rele-
vant antimicrobial resistance genes (García-Fernández & Carattoli, 
2020). The first description of fosA3 located on IncHI2 plasmids was 
reported	from	China	among	chicken	 isolates.	An	epidemic	 IncHI2/
ST3 plasmid (~230 kb) drives the dissemination of fosA3 along with 
blaCTX-14,	CXT-M-15, orCTX-M-65 in different geographic regions in China 
(Yang et al., 2014).
A	novel	plasmid-mediated	fosfomycin	resistance	gene,	fosL1, was 
recently	identified	in	a	collection	of	ESBL-producing	E. coli isolates 
from	Switzerland.	The	conjugative	40	kb	IncX1	plasmid	co-harbored	
the catB3 gene encoding a chloramphenicol acetyltransferase along 
with the fosfomycin resistance determinant. The authors performed 
an in silico	analysis	using	the	NCBI	database	and	identified	fosL1 in 
a Salmonella enterica isolate from the United States. Furthermore, 
another	putative	glutathione-S-transferase	FosL2	showing	only	five	
amino	acid	differences	 to	FosL1	was	 found	 in	a	second	S. enterica 
isolate. In contrast to the Swiss isolate, fosL1 and fosL2 were found 
to be located on IncQ1 and IncP-like plasmids, respectively (Kieffer 
et al., 2020).
The wide dissemination of resistance genes is most often linked 
to horizontal gene transfer via plasmids, but also other mobile struc-
tures like transposons and insertion elements are important features 
when studying transmission pathways. IS26 plays a key role in the 
dissemination and mobilization of fosfomycin-modifying enzymes 
and numerous descriptions of IS26 (composite) transposon-like 
structures have been published. Integrons are important genetic el-
ements for the acquisition of multiple resistance genes in bacteria. 
In contrast to mobile genetic elements, they are not considered to be 
mobile as such since they lack functions for self-mobility. However, 
fosfomycin resistance determinants have been described within 
type 1 integrons on plasmids. Yang et al. have compiled surrounding 
elements of fosA genes in Enterobacteriaceae (Yang et al., 2019).
Co-selection by other antimicrobials, especially third-gen-



















TA B L E  2 Characteristics	of	fosA-carrying plasmids from enterobacterial isolates in Europe






(frequency) Surrounding element Accession number Reference
2011 Germany 1978-1 fosA3 225 IncN blaCTX-M-65, floR, aac(6′)-
lb3, sul2
Yes (1.17 x 10−2) n.a. — Freitag et al. (2018)





1979-1 fosA3 245 IncHI2 blaCTX-M-14, floR, aac(3)-
IVa, sul2, tetA(A)
Yes (7.09 x 10−2) n.a. —
RH-1238 fosA3 187 IncA/C2 blaNDM-1, blaCMY-16, 










KR091911 Villa et al. (2015)
2011 France 27732 fosA4 145 IncF18:A-:B1 blaCTX-M-55 Yes n.a. — Lupo	et	al.	(2018)
2012 9 fosA3 n.a IncFII, Inc I1 n.a. Yes n.a. — Benzerara	et	al.	(2017)
12 fosA3 n.a. IncFII, Inc I1 n.a. Yes n.a. —
2013 34248 fosA3 48 IncF33:A1:B1 rmtB, blaCTX-M-55 No n.a. — Lupo	et	al.	(2018)
36 fosA3 n.a. IncFII n.a. Yes n.a. — Benzerara	et	al.	(2017)
19 fosA3 n.a. IncFII n.a. Yes n.a. —
34 fosA3 n.a. nontypable n.a. No n.a. —
24 fosA3 n.a. IncFII n.a. Yes n.a. —
2014 35 fosA3 n.a. IncFII n.a. Yes n.a. —
39 fosA3 n.a. IncFII n.a. Yes n.a. —
2015 42 fosA3 n.a. colE 
nontypable
n.a. Yes n.a. —
20 fosA5 n.a. IncN n.a. Yes n.a. —
2014 ESBL96 fosA3 71 IncF33:A-:B- blaCTX-M-15, blaTEM-1b-like Yes IS26-fosA3-orf1-orf2-
orf3-IS26
PRJNA608701 Baron	et	al.	(2020)
2012 Portugal C1728 fosA3 n.a. F2:A-:B- blaCTX-M-15 Yes IS26-fosA3-orf1-orf2-
orf3-IS26


























(frequency) Surrounding element Accession number Reference
2012 Switzerland R249 fosL1 40 IncX1 catB3 Yes (~10−2) ΔIS91-like-Tn7L-like-fosL1-
gnat-Tn7R-like-ΔIS91-
like
MN464149 Kieffer et al. (2020)
2013 376 fosA8 50 IncN n.a. Yes (~10−5) ΔsprT-fosA8-ΔsprT MN150127, 
PRJNA558667
Poirel et al. (2019)
21-13 fosA3 ~230 nontypable blaCTX-M-65, aph(4)-la, 
aadA1, aac(3)-IVa, 




NAPP00000000 Hindermann et al. 
(2017)
144-13 fosA3 ~230 nontypable blaCTX-M-65, aph(4)-la, 
aadA1, aac(3)-IVa, 













aAminoglycoside	resistance	genes:	aac(6’)-lb3, aph(3’)-IIa, aac(3)-IVa, strA, strB, aac(6’)-Ib, aadA5, aphA6, rmtB, aph(4)-la, aadA1, aac(3)-IVa, aph(3’)-lc; broad/extended-spectrum β-lactamase genes: 
blaCTX-M-65, blaCTX-M-125, blaCTX-M-14, blaCMY-16, blaCTX-M-55, blaCTX-M-15, blaTEM-1b-like; carbapenemases: blaNDM-1; chloramphenicol/florfenicol resistance genes: floR, catB3; macrolide resistance gene: mph(A); 
sulfonamide resistance genes: sul1, sul2; tetracycline resistance gene: tetA(A);	trimethoprim	resistance	genes:	dfrA7, dfrA14 
bUpstream elements of fosA3 not available. 
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self-transferable	plasmids	seem	to	play	a	major	role	in	the	spread	of	
plasmid-mediated fosfomycin resistance determinants. Furthermore, 
resistance genes against aminoglycoside (in particular rmtB), florfen-
icol (floR), or sulfonamide (sul1, sul2) are often co-located with fosA 
genes.
4  |  MOBILE FOSFOMYCIN RESISTANCE 
GENES IN ENTEROBAC TERIACE AE 
ISOL ATED AT THE HUMAN–ANIMAL–
ENVIRONMENT INTERFACE IN EUROPE
The first plasmid-encoded fosfomycin-modifying gene, fosA, was 
reported in clinical isolates of Serratia marcescens in 1980 in Spain 
(Mendoza et al., 1980). Nine fosfomycin-resistant S. marcescens were 
studied in more detail and two types of fosfomycin resistance genes 
harboring	 conjugative	 plasmids	 were	 identified	 (Mendoza	 et	 al.,	
1980). In at least one case, fosA was associated with the insertion 
sequence IS2921 in the composite transposon Tn2921 (Navas et al., 
1990). The results of a surveillance study performed fourteen years 
after the introduction of fosfomycin in Spain indicate that fosA is no 
longer confined to hospital environments since it could be detected 
in sewage samples in six out of seven provinces tested. Furthermore, 
fosA could be detected by hybridization in clinical isolates from three 
hospitals and the gene was carried by species of Enterobacteriaceae, 
Pseudomonas spp., and Acinetobacter spp. (Terán et al., 1988).
In the late nineties, an epidemiological multicentre survey was 
performed in Italy for which sixty out of 219 fosfomycin-resistant 
bacteria selected from more than 7400 urinary pathogens were 
screened for fosA and fosB. In only three enterobacterial isolates (1 
Enterobacter sp. and 2 E. cloacae), fosA could be detected by PCR 
(Arca	et	al.,	1997).	However,	the	location	of	fosA genes is uncertain 
since	hybridization	using	undigested	plasmid	DNA	failed.	With	the	
current state of knowledge, a possible chromosomal location of fosA 
is likely (Ito et al., 2017).
After	these	early	publications,	reports	on	mobile	fosfomycin	re-
sistance in Europe were sparse. The renewed interest in fosfomycin 
as a potential treatment against MDR Gram-negative bacilli and the 
first report of fosA3	2010	in	Japan	involving	ESBL-producing	E. coli 
reactivated the awareness of mobile fosfomycin resistance (Giske, 




Characteristics of enterobacterial isolates encoding plasmid-me-
diated fosA in Europe are summarized in Table 3. The first report of 
fosA3 in Europe was in a Salmonella enterica serovar Corvallis strain 
isolated from a migratory wild bird in Germany. The fosfomycin re-
sistance	 determinant	 was	 located	 on	 a	 large	 (187	 kb)	 conjugative	
plasmid	classified	as	IncA/C	encoding	blaNDM-1, blaCMY-16, fosA3, sul1, 
sul2, strA, strB, aac(6’)-Ib, aadA5, aphA6, tetA(A), mph(A), floR, dfrA7, 
and merA genes, which confer resistance to most β-lactam antibiotics 
including carbapenem, fosfomycin, co-trimoxazole, aminoglycoside, 
tetracyclines, and macrolides. The authors propose a possible ori-
gin	of	the	plasmid	in	the	Asiatic	region	according	to	complete	plas-
mid sequence analysis and the migration route of Milvus migrans 
which	includes	Europe	and	northern	Asia	during	the	summer	(Villa	
et al., 2015). However, retrospective studies revealed that fosA3 
was already present in Europe at least since 2012 in clinical iso-
lates	 in	Portugal,	France,	 and	Switzerland,	 respectively	 (Benzerara	
et al., 2017; Mendes et al., 2016; Mueller et al., 2019). While the 
isolate from the patient in Portugal was associated with a urinary 
tract	 infection	acquired	after	 traveling	 to	Asia	 (China,	Philippines),	
there was no history of international travel in the patient population 
studied	 in	France	 (Benzerara	et	al.,	2017;	Mendes	et	al.,	2016).	Of	
note, in the study of Mueller et al. (Mueller et al., 2019) two fosfomy-
cin-resistant E. coli isolates were identified which were tested neg-
ative for fosA1-A7 in PCR amplification although they exhibited an 
increased inhibition zone diameter on the agar plate in presence of 
FosA-inhibitor	sodium	phosphonoformate.	In	two	follow-up	studies,	
they identified three novel glutathione-S-transferase genes fosA8, 
fosL1, and fosL2, respectively (Kieffer et al., 2020; Poirel et al., 2019).
In more recent studies, fosA genes were reported from clinical 
isolates	from	Croatia,	France,	and	Spain	(Bedenić	et	al.,	2018;	Birgy	
et	 al.,	 2018;	 Loras	 et	 al.,	 2020)	 but	 only	 in	 the	 study	 from	 Spain	
were fosfomycin-resistant isolates explicitly investigated. Two iso-
lates out of 39 randomly selected fosfomycin-resistant E. coli from 
urine samples carried a plasmid-borne fosA3 gene and both were 
ESBL-producer	 causing	 complicated	 UTI	 (Loras	 et	 al.,	 2020).	 The	
focus of the study from Croatia was the epidemiology, antibiotic 
resistance	mechanisms,	and	routes	of	spread	of	OXA-48	carbapen-
emase among clinical isolates collected in 10 hospitals. Within this 
study, three fosA harboring enterobacterial isolates were identified 




infection. Whole-genome sequencing has shown that the strain pos-
sesses a total number of seventeen antimicrobial resistance genes 
including	 the	 ESBL	 gene	blaCTX-M-55, the glutathione-S-transferase 
gene fosA, the extended-spectrum aminoglycoside resistance meth-
ylase gene armA, and the mobile colistin resistance gene mcr-1. The 
combination of these resistance genes is particularly worrying be-
cause colistin and fosfomycin remain one of the last-resort thera-
peutic	 options	 in	 the	 case	 of	MDR	Gram-negative	 bacteria	 (Birgy	
et al., 2018).
Besides	 the	 description	 of	 a	 fosA3-positive S. enterica sero-
var, Corvallis isolate from a migratory bird in Germany, mobile 
fosfomycin-modifying genes have been described in animals in 
France.	As	part	of	a	global	survey	of	ESBLs	 in	animals	 in	France,	
the authors investigated a collection of 862 E. coli isolates sus-
pected	to	produce	an	ESBL.	Of	 those,	CTX-M-55-producing	 iso-
lates were further studied for their co-resistance to fosfomycin, 
aminoglycosides, fluoroquinolones, and colistin since blaCTX-M-55 is 
frequently co-localized with resistance genes such as fosA3, plas-



















TA B L E  3 Characteristics	of	enterobacterial	isolates	encoding	plasmid-mediated	fosA in Europe.







carbapenemase Resistance profile Reference
2011 Germany 1978-1 soy sprouts Escherichia coli A:ST10	(CC10) fosA3 CTX-M-65 n.a. Freitag et al. 
(2018)1978-4	(pCTX48) soy sprouts Escherichia coli A:	ST542 fosA3 CTX-M-125 n.a.
1979-1 soy sprouts Escherichia coli B1:ST527 fosA3 CTX-M-14 n.a.
2015 RH-1238 black kite Salmonella enterica 
serovar 
Corvallis
n.a fosA3 NDM-1 n.a. Villa et al. 
(2015)




2012 9 urine Escherichia coli ST559 (CC10) fosA3 CTX-M-55 n.a. Benzerara	et	al.	
(2017)12 urine Escherichia coli ST559 (CC10) fosA3 CTX-M-55 n.a.





36 blood Escherichia coli ST new fosA3 CTX-M-55 n.a.
19 urine Escherichia coli ST new fosA3 CTX-M-15 n.a.
34 urine Escherichia coli ST2015 fosA3 CTX-M-2 n.a.
24 urine Escherichia coli ST4508 fosA3 CTX-M-15 n.a.
2014 35 urine Escherichia coli ST69 fosA3 CTX-M-15 n.a.
39 joint	fluid Escherichia coli ST69 fosA3 CTX-M-15 n.a.
ESBL96 river Escherichia coli n.a. fosA3 CTX-M-15 n.a. Baron	et	al.	
(2020)2015 42 urine Escherichia coli ST457 fosA3 CTX-M-14 n.a.
20 feces Escherichia coli ST new fosA5 CTX-M-15 n.a.
RDP19 urine Escherichia coli ST219 fosAa  CTX-M-55 n.a. Birgy	et	al.	
(2018)
2012 Portugal C1728 urine Escherichia coli D:ST393 fosA3 CTX-M-15 AZM,	CIP,	CTX,	FEP,	FOS,	
GM, K, NET, NN, S, SMZ, 
TE, TMP
Mendes et al. 
(2016)































carbapenemase Resistance profile Reference
2012 Switzerland R249 urine Escherichia coli B1:ST	new fosL1 CTX-M-15 C,	CIP,	CTX,	FOS,	K,	NN,	
SMZ, TE, TMP
Kieffer et al. 
(2020)
n.a. patient Escherichia coli A:ST10	(CC10) fosA3 CTX-M-3 n.a. Mueller et al. 
(2019)2013 n.a. patient Escherichia coli ST117 fosA3 CTX-M-3 n.a.
n.a. patient Escherichia coli ST359 (CC101) fosA3 CTX-M9 n.a.
n.a. patient Escherichia coli ST69 fosA3 CTX-M-15 n.a.
n.a. patient Escherichia coli ST12 fosA4 n.a. n.a.
376 urine Escherichia coli ST40 fosA8 CTX-M-15 CIP,	CTX,	FOS,	K,	NN,	TE, Poirel et al. 
(2019)
21-13 (N13-0312) urine Salmonella enterica 
serovar Infantis




144-13 (N13-2103) food Salmonella enterica 
serovar Infantis
ST 32 fosA3 CTX-M-65 AM,	C,	CF,	CTX,	FOS,	GM,	
K,	NA,	S,	SMZ,	TE,	TMP
2015 125-15 (N15-1708) food Salmonella enterica 
serovar Infantis
ST 32 fosA3 CTX-M-65 AM,	C,	CF,	CTX,	FOS,	NA,	
SMZ, TE, TMP
2017 Croatia 18464 urine Escherichia coli n.a. fosA* OXA-48 n.a. Bedenić	et	al.	
(2018)




tobramycin; S, streptomycin; SMZ, sulfamethoxazole; ST, Sequence type; TE, tetracycline; TMP: trimethoprim.
afosA-type	not	further	analyzed.	
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rRNA	methylases	such	as	rmtB, a gene-encoding pan-aminoglyco-
side	resistance	(Lupo	et	al.,	2018;	Yang	et	al.,	2014).	One	bovine	
isolate and one isolate from a monkey encoded fosA3 and fosA4, 
respectively. FosA3 was co-located with rmtB and blaCTX-M-55 on 
a	 48	 kb	 IncF33:A1:B1	 plasmid	whereas	 fosA4 was detected and 
co-located with blaCTX-M-55	on	a	145	kb	IncF18:A-:B1	plasmid.	Of	
note, the monkey isolate (fosA4)	was	of	Asian	origin	as	this	animal	
was	 introduced	 to	France	 through	 a	French	 animal	 centre	 (Lupo	
et al., 2018).
Also	 in	 France,	 ESBL-harboring	 plasmids	 from	 E. coli isolated 
from river water were studied recently. Of the 21 randomly selected 
isolates,	one	plasmid	(IncF33:A-:B-)	contained	the	resistance	deter-
minants blaCTX-M-55, blaTEM-1b-like, and fosA and was highly similar to a 
plasmid from an E. coli	of	chicken	origin	in	China	(Baron	et	al.,	2020).
In	the	context	of	a	study	on	ESBL-encoding	plasmids	among	E. coli 
isolates from fresh vegetables, three plasmids were found co-har-
boring blaCTX-M and fosA3.	The	conjugative	plasmids	were	found	in	
E. coli isolates originating from soy sprouts from the Netherlands 
in 2011 (Freitag et al., 2018). The presence of multidrug resistance 
plasmids in E. coli isolates in vegetables underlines the importance of 
greens as a possible reservoir for resistance genes.
Salmonella enterica serovar Infantis has emerged as the fourth 
most common serovar causing human salmonellosis in Europe, and it 
is one of the most frequently reported serovar in broilers and broiler 
meat	 (EFSA,	2016).	This	 serovar	has	been	associated	with	a	 resis-
tance and virulence megaplasmids (270-320 kb) pESI (plasmid for 
emerging S. enterica serovar Infantis). One subgroup of this pESI-like 
plasmids includes a multidrug resistance plasmid encoding up to ten 
different resistance genes including blaCTX-M-65 and fosA3. Highly 
similar plasmids have been described in a human isolate from Italy, 
along with the poultry production chain in the United States and one 
human and two food isolates in Switzerland, respectively (Franco 
et al., 2015; Hindermann et al., 2017; Tate et al., 2017).
Tracking the transfer dynamics of resistance plasmids is an al-
most impossible task. However, the data point out that fosA3 was 
present in isolates of human, animal, food, and environmental origin. 
At	the	human–environment	interface,	fosA3 was found to be located 
on the same plasmid backbone, that is, IncF. Surface waters are sup-
posed to be putative reservoirs of multiresistant bacteria since they 
collect material from wastewater plants, water of urban or industrial 
effluents, and agricultural activities. Furthermore, wastewater has 
been described to reflect the current status of antibiotic-resistant 
bacteria in the population (Kwak et al., 2015). IncN plasmids carry-
ing fosA3 seem to circulate among the human–food–animal–envi-
ronment since such plasmids were described from all these origins. 
Other plasmid incompatibility types than IncF and IncN appear spo-
radically which makes tracking even more difficult.
This review has several limitations. First, fosfomycin resistance 
is not routinely tested in most monitoring and surveillance studies 
and if so, the resistance mechanism is often not further analyzed. 
Second, in many studies, fosfomycin resistance is not of main in-
terest and is only detected by WGS and data analysis. These might 
cause underestimation of the current situation of the spread of mo-
bile fosfomycin-modifying enzymes.
5  |  CONCLUSIONS
The detection of mobile fosfomycin resistance genes in 
Enterobacteriaceae has increased in recent years. Certain fosA 
types (e.g., fosA3) are predominant and their occurrence is fre-
quently linked to specific plasmids (e.g., IncFII family, IncN). Data 
from recent studies suggest that the therapeutic use of other an-
tibiotic classes promotes the emergence and dissemination of fos-
fomycin-resistant Enterobacteriaceae, since additional resistance 
genes are often present, first, and foremost extended-spectrum 
beta-lactamases. Several studies highlighted in this review provide 
evidence for the transmission of mobile fosfomycin resistance genes 
in Enterobacteriaceae at the human–animal–environment interface. 
The implementation of international and national mitigation strate-
gies based on a One Health approach, including increased surveil-
lance and monitoring of fosfomycin resistance in Enterobacteriaceae 
as well as the optimization of therapeutic strategies are necessary.
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